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Hepatic cholesterol synthesis. hepatic cyclic AMP, and portal and peripheral insulin and 
glucagon levels were investigated in nine dogs and three baboons after complete portacaval shunt. 
Cholesterol synthesis as measured with acetate incorporation was reduced in both species, Hepatic 
cyclic AMP increased in dogs, Changes in portal and systemic insulin were inconsistent. but hyper-
glucagonemia occurred regularly, Diminished hepatic cholesterol synthesis is apparently one 
factor, although probably not the only one, in the antilipidemic effect of portacaval shunt. This 
altered cholesterol metabolism may be due to a change in the hormonal environment of the liver 
caused by portal diversion, 
INTRODUCTION 
In rats [17,25], dogs [1-13,19,22,33,36], 
pigs [8,,9], baboons [28, 33], and humans [4, 
34, 351 completely diverting portacaval 
shunt causes a decrease in serum cholesterol. 
The mechanism of this antilipidemic effect 
is, however, a matter of dispute. We 
reported earlier that there was a diminution 
of hepatic cholesterol synthesis [33] but this 
effect in dogs has been denied by Coyle 
[11-13] and Guzman l19] and their associ-
ates. In this communication, the role of 
altered hepatic cholesterol synthesis in 
lowering serum cholesterol has been re-
examined in dogs and baboons subjected to 
portal diversion. 
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Ph,D., and Mrs, Ellie Groeneboer is gratefully ac-
knowledged. 
2 The work was supported by Research Grants 
MRIS 8118-01 and 7227-01 from the Veterans Ad-
ministration; by Grants AM-I7260 and AM-07772 
from the National Institutes of Health: and by Grants 
RR-00051 and RR-00069 from the General Clinical 
Research Centers Program of the Division of Research 
Resources, National Institutes of Health, 
MATERIALS AND METHODS 
Experimental preparation. Nine dogs 
weighing 12.7 to 31.8 kg had side-to-side 
portacaval anastomoses with high ligation of 
the portal vein creating a functional complete 
end-to-end shunt [33]. Animals were studied 
and then sacrificed 1 month after operation. 
Three female baboons weighing 11.8 to 
17.5 kg had end-to-side portacaval shunts. 
Three months later, a liver biopsy and blood 
sample were taken and the animals were 
sacrificed. 
Dogs were anesthetized with ketamine 
hydrochloride or phenylcyclidine hydro-
chloride, and succinylcholine chloride for 
both operation and sacrifice. Phenycyciidine 
hydrochloride was used as anesthesia for 
both procedures in baboons. 
Cholesterol determination. All serum and 
tissue samples were obtained between 9:00 
and 10:00 AM after a 14-hr fast. For both 
serum and liver extracts, cholesterol con-
centration was determined by the method 
of Zlatkis and his associates [39]. 
Cholesterol synthesis. A specimen was 
excised from the liver, rapidly cooled in ice-
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• FIG. I. Thin-layer chromatography showing separa-
tion of raw extract (bottom) into cholesterol (middle, C) 
and cholesterol palmitate (top, CPl. TP, CP, and C 
are controls for cholesterol tripalmitate, cholesterol 
palmitate, and cholesterol, respectively. Numbered 
samples are from different dogs. 
cold saline, and then sliced. Two hundred 
milligrams of slices was placed in I5-ml 
incubation flasks containing 2 ml of Krebs-
Hanseleit bicarbonate buffer with a pH of 
7.4,30 JLmole of sodium acetate, and 20 JLCi 
of [2-14C]acetic acid sodium salt with specific 
activity of 50 mCi/mmole. After 2 hr of 
incubation at 37°C, the reaction was ter-
minated by introduction of 2.4 ml of 15% 
KOH in absolute ethanol under an atmos-
phere of 95% 02-C02' These samples were 
then saponified over steam for 2 hr and 
extracted with petroleum ether to remove 
nonsaponifiable lipids (three 20-ml ex-
tractions). 
Petroleum ether extracts from each sample 
were pooled, dried out, and the residue taken 
up in 4 ml of twice-distilled chloroform. 
Cholesterol determinations were made on a 
digest of this extract by the Lieberman-
Burchard reaction [39]. The remaining 
chloroform extract was used for determining 
the cholesterol synthesis using two different 
methods: 1.5-ml samples from three dogs 
and all baboons were subjected to digitonin 
purification according to the principle of 
Sperry [32]; I-ml samples from all dogs were 
subjected to thin-layer chromatography in 
1:1 ethyl acetate-cyclohexane. With this 
latter method, using cholesterol and choles-
terol palmitate and tripalmitate as controls, 
we achieved good separation of cholesterol 
from contaminants (Fig. 1). 
With both methods, radioactivity of the 
extracted cholesterol was determined by 
liquid scintillation counting using lnstagel 
mixture. The rate of cholesterol synthesis 
was expressed as disintergrations per minute 
per 100 JLg of cholesterol extract. 
Cyclic adenosine 3,5'-monophosphate 
(cyclic AMP). Cyclic AMP concentration 
in the liver was analyzed by the radioim-
munoassay of Harper and Brooker [20] from 
a trichloroacetic acid extract that had been 
passed through a Dowex 50 column (700-
400 mesh). 
To determine the rate offormation ofliver 
cyclic AMP, three normal dogs and five dogs 
1 month after portacaval shunt were sub-
jected to an aminophylline infusion test 
under anesthesia. As described by Robison 
and his group [20], the methylxanthines in 
appropriate dosages are essentially complete 
inhibitors of cyclic AMP phosphodiesterase. 
Butcher and Sutherland [7] and Cheung 
[10] have shown this phosphodiesterase to 
be the principal enzyme involved in the 
catabolism of cyclic AMP. Rapid intravenous 
infusion of animophylline inhibits this 
enzyme and allows the quantitation of cyclic 
AMP formation. Infusion over 6 min per-
mits prompt completion of studies before 
the onset of delayed aminophylline-induced 
effects, such as changes in insulin levels 
which might by themselves affect the 
metabolism of cyclic AMP. 
Control biopsy specimens ofthe right and 
left lobes were taken for baseline levels. 
Then, 3 g of aminophylline in 300 ml of 5% 
dextrose in normal saline solution were 
infused by way of a peripheral vein at a 
constant rate over 6 min. Biopsy specimens 
of 100 to 200 mg in weight were removed 
from both sides of the liver at 2, 4, and 6 
min after the infusion was begun, taking 
care to minimize blood loss. These were 
immediately frozen in liquid nitrogen and 
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assayed for cyclic AMP as previously 
described. 
Glucagon and insulin determinations. 
Glucagon and insulin concentrations in both 
portal vein and inferior vena cava were 
determined in the laboratory of Dr. R. H. 
Unger of Dallas, Texas, in eight of the nine 
dogs. Blood specimens were drawn before 
portacaval shunt and again just prior to 
sacrifice. Insulin analysis was by the im-
munoassay of Herbert and his associates 
[21]. Glucagon was determined by the radio-
immunoassay of Faloona and Unger [18]. 
The primary pancreatic glucagon measured 
~ith this technique has a molecular weight 
of 3500, although other larger moieties have 
some activity. 
RESULTS 
Clinical behavior. Dogs lost weight from 
19.1 ± 5.3 to 12.4 ± 2.4 (SD) kg during the 
1 month observation period. None developed 
encephalopathy. The baboons weighed] 1.8, 
17.5, and 13.6 kg at the time of portacaval 
shunt. During the 3 months, their weights 
fell to 9.5,13.2, and 9.7 kg. Although all had 
hair loss, none had obvious encephalopathy. 
At sacrifice, all shunts were explored and 
found to be patent. 
Serum cholesterol. In dogs, serum cho-
lesterol fell from 160 ± 54 to 131 ± 39 mg! 
100 ml. In baboons, cholesterol decreased 
from 129 ± 27 to 83 ± 12 mg/IOO ml. Serum 
cholesterol decreased in seven of nine dogs 
and in all three baboons. 
Liver cholesterol. Liver cholesterol in-
creased significantly following portacaval 
shunt in dogs (Table 1). No significant change 
in liver cholesterol was demonstrated in the 
baboons (Table 1). 
Cholesterol synthesis. In dogs, hepatic 
cholesterol synthesis decreased to a signifi-
cant degree following portacaval shunt 
(Table 2). Rates of cholesterol synthesis ob-
tained by the digitonin method and by thin-
layer chromatography in dogs were com-
parable and demonstrated decreases. Highly 
significant decreases were found in the 
TABLE I 
HEPATIC CHOLESTEROL IN DOG AND BABOON 
BEFORE AND AFTER PORTACAVAL SHUNT 
Cholesterol (fLg/g wet liver) 
Animals Before After 
Dogs 
7 1520 2291 
8 1580 1855 
9 1596 2006 
16 2130 2693 
17 
22 1205 2149 
32 22% 2410 
33 2095 1268 
37 2105 2965 
M ± SD 1886 ± 363 2267 ± 385 
p* < 0.001 
Baboons 
1 3546 3252 
2 3183 4911 
4 3684 3564 
M ± SD 3471 ± 211 4075 ± 595 
P* NS 
* For paired data by Student's I test. 
baboons using the digitonin method. Because 
liver cholesterol had increased in some 
animals, changes in the absolute role of cho-
lesterol synthesis were also computed 
(Table 2). 
Hormonal studies. Mter portacaval shunt, 
insulin levels in the portal vein decreased 
from 78 ± 76 to 60 ± 58 ILU/ml. Insulin 
in the vena cava increased from 21 ± 20 to 
31 ± 25ILU/ml. Neither change was signifi-
cant. On the other hand, glucagon concen-
tration increased significantly from 151 
± 76 to 328 ± 196 pg!ml in portal vein and 
from 59 ± 41 to 183 ± 91 pg!ml in vena 
cava. In two dogs in whom cholesterol 
synthesis decreased (dogs 16-22 in Table 2), 
portal venous glucagon concentrations did 
not increase after portacaval shunt. 
Cyclic AMP. Cyclic AMP increased sig-
nificantly in dog liver after portacaval shunt 
(Table 3). This increase was not documented 
in baboon liver. 
Aminophylline test. The rate of cyclic 
AMP formation as determined by the amino-
---_ .. _---
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TABLE 2 
HEPATIC CHOLESTEROL SYNTHESIS IN DOG AND BABOON LIVER BEFORE AND AFTER PORTACAVAL SHUNT 
Digitonin-thin-Iayer chromatography Digitonin 
Cholesterol (dpmlIOO I'g of hepatic cholesterol) Cholesterol (dpm/IOO I'g of hepatic cholesterol) 
Percentage decrease Percentage decrease 
Adjusted for Adjusted for 
From increased hepatic From increased hepatic 
Animals Before After raw data cholesterol Before After raw data cholesterol 
Dogs 
7 
8 
9 
16 
17 
22 
32 
33 
37 
M" SD 
M" SD 
3291 5737 
5839 3494 
1802 495 
3565 496 
5031 2269 
2932 896 
2380 1220 
3324 5002 
1751 674 
3323 " 1375 2254 " 2025 
P** < 0.001 
... Hepatic cholesterol data not available. 
"'* Paired data compared by Student's t test. 
40 28 
72 66 
86 82 
54 
68 45 
49 46 
61 46 
phylline test in dogs (Fig. 2) was not signifi-
cantly altered by portacaval shunting. Higher 
baseline levels of hepatic cyclic AMP were 
again noted in many of the dogs that had 
undergone portacaval shunting. 
DISCUSSION 
Although it has been well established that 
portal diversion lowers serum cholesterol 
in several species, the mechanism of this 
effect has been a matter of dispute. Our 
studies [33] in the dog, as well as investiga-
tions in the rat [17, 23], pig [8, 9], and human 
[4] have suggested that a reduction in cho-
lesterol or low-density lipoproteins (LDL) 
synthesis is responsible at least in part for 
the cholesterol falls. However, studies by 
Coyle and his associates have not been 
confirmatory [11-13, 19]. 
Our present investigations have shown 
once more that hepatic cholesterol synthesis 
is reduced following portacaval shunt in 
both dogs and baboons. For the canine 
2954 286 
4500 2097 
3962 1205 
3805 " 640 1195 " 738 
P** < 0.001 
1682 140 
1237 415 
966 461 
1295 " 235 338 " 141 
P** < 0.01 
90 
53 
69 
91 
66 
52 
88 
64 
91 
48 
54 
studies, two techniques for measuring cho-
lesterol synthesis were used which differed 
in the way in which cholesterol was sepa-
rated from other lipids. Both measured 
labeled acetate incorporation. The results 
were almost identical. In calculating synthe-
sis rates, the increased hepatic cholesterol 
content in the dogs was taken into account. 
Although the adjustment lessened the falls 
in cholesterol synthesis, the reductions 
were still substantial and significant. Ul-
timately, the calculations of hepatic choles-
terol synthesis were per aliquots of hepatic 
tissue. Portacaval shunt in dogs [23] and 
baboons [28, 33] has been shown invariably 
to produce atrophy with a striking reduction 
of total hepatic mass. Thus, the expression 
of results undoubtedly was a striking under-
statement of the actual reduction in total 
hepatic cholesterol synthesis. 
The exact mechanism by which portal 
diversion reduced cholesterol synthesis 
remains open to speculation. Our earlier 
experiments in dogs [33] suggested that one 
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reason might be deprivation of the liver of 
endogenous insulin resulting in a moderately 
severe liver injury. Alternatively, Eaton [16] 
has proposed that changes in glucagon 
metabolism might be important in causing 
the antilipidemic effect. Portacaval shunting 
has also been demonstrated to cause in-
creases in serum glucagon concentration 
126, 30, 31]. Glucagon in pharmacologic 
[27] or physiologic [37] doses has been 
shown to decrease hepatic cholesterol syn-
thesis possibly via an increase in hepatic 
cyclic adenosine 3' ,5'-monophosphate 
(cyclic AMP). We therefore also measured 
serum glucagon and hepatic cyclic AMP 
changes following portal diversion in an 
attempt to correlate them with cholesterol 
synthesis rates. 
In the present study, no further informa-
tion about insulin was adduced. The periph-
eral hyperinsulinemia that has been described 
after portacaval shunt l3, 14, 15J was not 
TABLE 3 
CYCLIC AMP CONCENTRATION IN DOG AND BABOON 
LIVER BEFORE AND AFTER PORTACAVAL SHUNI 
cAMP (pmol/g of wet liver) 
Animals Before After 
Dogs 
7 778 947 
8 565 1940 
9 1141 1949 
16 1590 2798 
17 1147 2085 
22 964 518 
32 757 1232 
33 730 1345 
37 653 1432 
M ± SD 925 ± 322 1583 ± 682 
P* < 0.01 
Baboons 
1 920 876 
2 618 
4 763 695 
M ± SD 841 ± 78 729 ± 108 
p* NS 
* Compared to preoperative value using Student's 
t test for paired data. 
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FIG. 2. Aminophylline test results showing cyclic 
AMP generated at 2. 4, and 6 min for three normal 
and five shunted dogs. 
consistently seen. However, increased 
glucagon levels in the systemic venous blood 
were regularly observed in confirmation of 
earlier reports [26, 30, 31]. As might be 
expected with hyperglucagonemia in com-
bination with a bypassing of insulin around 
the liver, the hepatic cyclic AMP was con-
sistently elevated in the dogs, but, sur-
prisingly, not in the baboons. The canine 
increases occurred in spite of the fact that 
cyclic AMP production as measured by the 
aminophylline test was not strikingly in-
creased. In addition, cyclic AMP increased 
despite the known decrease in responsive-
ness of adenyl cyclase receptors to glucagon 
stimulation in hyperglucagonemic states 
[38]. Elevation in cyclic AMP has been de-
scribed in inhibiting cholesterol synthesis 
[2, 5, 6]. 
These experiments have added weight to 
the contention that reduced hepatic choles-
terol synthesis is at least part of the reason 
for the antilipidemic effect ofthe portacaval 
shunt, although it seems unlikely that this 
is the sole explanation. Ahrens [1] has 
speculated than an increased loss of bile 
acids with an obligatory drain on the choles-
terol pool is a major contributing factor. 
Other possibilities have been suggested by 
Kuo et al. [24] and Coyle et al. [12]. 
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